130 related articles for article (PubMed ID: 9326761)
21. Amelioration of experimental autoimmune uveoretinitis with nuclear factor-{kappa}B Inhibitor dehydroxy methyl epoxyquinomicin in mice.
Iwata D; Kitaichi N; Miyazaki A; Iwabuchi K; Yoshida K; Namba K; Ozaki M; Ohno S; Umezawa K; Yamashita K; Todo S; Ishida S; Onoé K
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2077-84. PubMed ID: 19907030
[TBL] [Abstract][Full Text] [Related]
22. Amelioration of experimental autoimmune uveoretinitis by aldose reductase inhibition in Lewis rats.
Yadav UC; Shoeb M; Srivastava SK; Ramana KV
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8033-41. PubMed ID: 21900376
[TBL] [Abstract][Full Text] [Related]
23. Immunomodulatory effects of linomide in animals immunized with immunopathogenic retinal antigens: dissociation between different immune functions.
Shirkey BL; Slavin S; Vistica BP; Podgor MJ; Gery I
Clin Exp Immunol; 1997 Jun; 108(3):539-44. PubMed ID: 9182904
[TBL] [Abstract][Full Text] [Related]
24. Induction of experimental autoimmune uveoretinitis in Lewis rats with purified recombinant human retinal S-antigen fusion protein.
Roberts AJ; Kasp E; Stanford M; Dumonde DC; Banga JP
Eur J Immunol; 1992 Apr; 22(4):951-6. PubMed ID: 1551407
[TBL] [Abstract][Full Text] [Related]
25. Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats.
Kawashima H; Fujino Y; Mochizuki M
Invest Ophthalmol Vis Sci; 1988 Aug; 29(8):1265-71. PubMed ID: 2458329
[TBL] [Abstract][Full Text] [Related]
26. Adoptive transfer of experimental autoimmune uveoretinitis in rats. Immunopathogenic mechanisms and histologic features.
Mochizuki M; Kuwabara T; McAllister C; Nussenblatt RB; Gery I
Invest Ophthalmol Vis Sci; 1985 Jan; 26(1):1-9. PubMed ID: 3967952
[TBL] [Abstract][Full Text] [Related]
27. Experimental autoimmune uveoretinitis (EAU) induced by retinal interphotoreceptor retinoid-binding protein (IRBP): differences between EAU induced by IRBP and by S-antigen.
Fox GM; Kuwabara T; Wiggert B; Redmond TM; Hess HH; Chader GJ; Gery I
Clin Immunol Immunopathol; 1987 May; 43(2):256-64. PubMed ID: 3494559
[TBL] [Abstract][Full Text] [Related]
28. LX211 (voclosporin) suppresses experimental uveitis and inhibits human T cells.
Cunningham MA; Austin BA; Li Z; Liu B; Yeh S; Chan CC; Anglade E; Velagaleti P; Nussenblatt RB
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):249-55. PubMed ID: 18708627
[TBL] [Abstract][Full Text] [Related]
29. Suppression of experimental autoimmune uveoretinitis by prazosin, an alpha 1-adrenergic receptor antagonist.
Ruiz-Moreno JM; Misiuk-Hojlo M; Thillaye B; de Kozak Y
Curr Eye Res; 1992; 11 Suppl():135-40. PubMed ID: 1424739
[TBL] [Abstract][Full Text] [Related]
30. Induction of experimental autoimmune uveoretinitis by T-cell lines.
Rozenszajn LA; Muellenberg-Coulombre C; Gery I; el-Saied M; Kuwabara T; Mochizuki M; Lando Z; Nussenblatt RB
Immunology; 1986 Apr; 57(4):559-65. PubMed ID: 3485569
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity.
Zhang X; Ren X; Li G; Jiao C; Zhang L; Zhao S; Wang J; Han ZC; Li X
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3143-52. PubMed ID: 21296818
[TBL] [Abstract][Full Text] [Related]
32. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols.
Gregerson DS; Obritsch WF; Donoso LA
J Immunol; 1993 Nov; 151(10):5751-61. PubMed ID: 7693817
[TBL] [Abstract][Full Text] [Related]
33. Neutralizing tumor necrosis factor-alpha activity suppresses activation of infiltrating macrophages in experimental autoimmune uveoretinitis.
Robertson M; Liversidge J; Forrester JV; Dick AD
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3034-41. PubMed ID: 12824249
[TBL] [Abstract][Full Text] [Related]
34. Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide.
Keino H; Kezuka T; Takeuchi M; Yamakawa N; Hattori T; Usui M
Arch Ophthalmol; 2004 Aug; 122(8):1179-84. PubMed ID: 15302659
[TBL] [Abstract][Full Text] [Related]
35. Peripheral expression of rod photoreceptor arrestin induces an epitope-specific, protective response against experimental autoimmune uveoretinitis.
McPherson SW; Roberts JP; Gregerson DS
Curr Eye Res; 2005 Jun; 30(6):491-502. PubMed ID: 16020282
[TBL] [Abstract][Full Text] [Related]
36. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.
Sun M; Yang P; Du L; Zhou H; Ren X; Kijlstra A
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):383-9. PubMed ID: 19696173
[TBL] [Abstract][Full Text] [Related]
37. Antigen-directed retention of an autoimmune T-cell line.
Lightman SL; Caspi RR; Nussenblatt RB; Palestine AG
Cell Immunol; 1987 Nov; 110(1):28-34. PubMed ID: 2960461
[TBL] [Abstract][Full Text] [Related]
38. Suppression or exacerbation of experimental autoimmune uveoretinitis in Lewis rats by pretreatment with or without an autoantigenic peptide in aluminum hydroxide.
Ozaki A; Fukata K; Fukushima A; Yasuoka M; Yoshida O; Ueno H
Jpn J Ophthalmol; 2003; 47(1):102-6. PubMed ID: 12586187
[TBL] [Abstract][Full Text] [Related]
39. Splenectomy abrogates the induction of oral tolerance in experimental autoimmune uveoretinitis.
Suh ED; Vistica BP; Chan CC; Raber JM; Gery I; Nussenblatt RB
Curr Eye Res; 1993 Sep; 12(9):833-9. PubMed ID: 8261794
[TBL] [Abstract][Full Text] [Related]
40. [Participation of sodium iodate in the induction of experimental autoimmune uveoretinitis (EAU)].
Tanaka T
Nippon Ganka Gakkai Zasshi; 1991 Nov; 95(11):1077-84. PubMed ID: 1759647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
